Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06909968
What this trial is testing

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Who this might be right for
CancerChronic Renal FailureChronic Obstructive Pulmonary Disease+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 178
Not applicableUnknownNCT05007340
What this trial is testing

ILD-SARDs Registry and Biorepository

Who this might be right for
Interstitial Lung DiseaseSystemic Autoimmune DiseaseRheumatic Diseases+6 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441278
What this trial is testing

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NS Pharma, Inc. 177
Not applicableStudy completedNCT01695408
What this trial is testing

Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Technische Universität Dresden 1,232
Not applicableUnknownNCT03229343
What this trial is testing

Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Not applicableStudy completedNCT01935726
What this trial is testing

Pulmonary Fibrosis Contact Registry

Who this might be right for
Pulmonary Fibrosis of Any CausePrimary Supporters/Caretakers of Patients With Pulmonary Fibrosis
National Jewish Health 300
Not applicableEnded earlyNCT00744614
What this trial is testing

Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients

Who this might be right for
AsthmaChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease
Lahey Clinic 70
Not applicableStudy completedNCT04521426
What this trial is testing

Ventilator-associated Injury (VAI) in Chronic Home Mechanical Ventilation

Who this might be right for
Respiratory FailureLong-term Non-invasive Ventilation
University Medical Center Groningen 15
Not applicableLooking for participantsNCT06948916
What this trial is testing

Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Diseases (ILD)Exercise CapacityUpper Extremity
Gazi University 34
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Early research (Phase 1)Looking for participantsNCT05988463
What this trial is testing

Dose-Escalation Study of Artesunate Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Joseph C. Wu 15
Not applicableLooking for participantsNCT06883448
What this trial is testing

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisInterstitial Lung Disease (ILD)
Erasmus Medical Center 220
Not applicableNot Yet RecruitingNCT07722507
What this trial is testing

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Study completedNCT02389400
What this trial is testing

Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

Who this might be right for
Langerhans Cell Histiocytosis
Peking Union Medical College Hospital 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704
What this trial is testing

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more
National Cancer Institute (NCI) 9
Not applicableUnknownNCT05105230
What this trial is testing

Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease

Who this might be right for
Rheumatoid Arthritis
Assiut University 66
Not applicableStudy completedNCT05779007
What this trial is testing

Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 2,778
Testing effectiveness (Phase 2)Study completedNCT02477709
What this trial is testing

Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6
Not applicableEnded earlyNCT04238871
What this trial is testing

RaDiCo PID Cohort (RaDiCo-ILD Cohort in English)

Who this might be right for
Idiopathic Interstitial Pneumopathy/Pneumopathy Interstitial DiffusePaediatric and Adult Patients
Institut National de la Santé Et de la Recherche Médicale, France 1,600
Post-approval studies (Phase 4)Study completedNCT01744067
What this trial is testing

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Oslo University Hospital 132
Next Page